Arcutis Biotherapeutics Inc
ARQT
Market Cap$1.81B
Close$
$-8.09
159.8% downside
Current Fair Value
159.8% downsideOvervalued by 159.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.81 Billion |
|---|---|
| Enterprise Value | $1.85 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.16 |
| Beta | 1.68 |
| Outstanding Shares | 124,918,560 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -13.59 |
|---|---|
| PEG | 188.52 |
| Price to Sales | 13.52 |
| Price to Book Ratio | 13.52 |
| Enterprise Value to Revenue | 13.32 |
| Enterprise Value to EBIT | -10.15 |
| Enterprise Value to Net Income | -10 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.7 |
Revenue Sources
No data
Insider Trades
ESG Score
No data